Umb Bank, N.A. United Therapeutics Corp Transaction History

Umb Bank, N.A.

$6.26 Billion
Q2 2025

A detailed history of Umb Bank, N.A. transactions in United Therapeutics Corp stock. As of the latest transaction made, Umb Bank, N.A. holds 1,308 shares of UTHR stock, worth $565,958. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,308

Previous 1,289 1.47%

Holding current value

$565,958

Previous $370,000 1.35%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	BUY	$276.47 - $328.4 $5,252 - $6,239	19 Added 1.47%	1,308 $375,000
Q1 2025 Apr 14, 2025	BUY	$304.42 - $380.78 $57,230 - $71,586	188 Added 17.08%	1,289 $397,000
Q4 2024 Jan 16, 2025	BUY	$348.66 - $410.0 $17,781 - $20,910	51 Added 4.86%	1,101 $388,000
Q3 2024 Oct 08, 2024	BUY	$311.04 - $363.55 $30,792 - $35,991	99 Added 10.41%	1,050 $376,000
Q2 2024 Jul 29, 2024	SELL	$228.26 - $319.04 $40,858 - $57,108	-179 Reduced 15.84%	951 $302,000
Q1 2024 Apr 26, 2024	SELL	$210.76 - $249.51 $40,255 - $47,656	-191 Reduced 14.46%	1,130 $259,000
Q4 2023 Jan 23, 2024	SELL	$214.88 - $256.94 $3,438 - $4,111	-16 Reduced 1.2%	1,321 $290,000
Q3 2023 Oct 18, 2023	BUY	$211.82 - $248.24 $8,684 - $10,177	41 Added 3.16%	1,337 $301,000
Q3 2022 Oct 13, 2022	SELL	$203.3 - $244.17 $2,033 - $2,441	-10 Reduced 0.77%	1,296 $271,000
Q2 2022 Jul 20, 2022	BUY	$174.81 - $241.14 $109,256 - $150,712	625 Added 91.78%	1,306 $308,000
Q4 2021 Feb 09, 2022	BUY	$184.32 - $216.08 $125,521 - $147,150	681 New	681 $147,000

Others Institutions Holding UTHR

# of Institutions

750

Shares Held

43.7M

Call Options Held

340K

Put Options Held

318K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $19.7B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account